Stock Taper
NXGLW
NEXGEL, INC.
NASDAQ
$0.01
▲ UP 1.63% (0.00)

KEY STATISTICS

Market Cap$969.30 K
52w High$0.31
52w Low$0.01
Dividend Yield
Frequency
P/E-0.03
Volume7.57K
Shares Out.72.42M

COMPANY

LEADERSHIP

Adam R. Levy
CHIEF EXECUTIVE
Adam R. Levy

COMPENSATION 2026

Salary$373,077
Stock Awards$100,000
Incentive Plan Pay$0
All Other Comp.$10,500
Total$877,177

ABOUT

SECTOR
Healthcare
WENT PUBLIC
December 22, 2021
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
19

UPCOMING EARNINGS

DateNov 17, 2026
DayTuesday
Rev. Est.$4.19M
NOV
17
TUE

PRICE

$0.01 ▲ UP 1.63% (+$0.00)
$0.01$0.01$0.02$0.02$0.029:30 AM10:28 AM11:27 AM12:26 PM1:24 PM2:22 PM3:21 PM0.01

About NEXGEL, Inc.

https://nexgel.com ↗

NEXGEL, Inc. manufactures high water content hydrogels for wound care, diagnostics, drug delivery, and cosmetics, offering products like patches and masks, and is based in Langhorne, PA.

INDUSTRY

Medical - Instruments & Supplies

A PRODUCT NEXGEL, INC. IS KNOWN FOR

Glutacin
Glutacin

A digestive enzyme product designed for individuals with gluten sensitivity. It represents NEXGEL's latest expansion into the consumer wellness market, with a full marketing and promotional plan initiated in early 2026.

COMPETITORS

Revenue by Products

IconPRODUCTQ2-2024Q4-2024Q1-2025Q2-2025
Contract Manufacturing$347K $1.18M $781K $513K
Other Incomes$33K $198K $49K $72K

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book5
Overall Score2

INSIDER TRADES

DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Levy Adam R.
Purchase · 160.0K shares
2026-07-23
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Levy Adam R.
Sale · 6.0K shares
2026-06-18
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Levy Adam R.
Sale · 5.0K shares
2026-06-23
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Levy Adam R.
Sale · 3.0K shares
2026-06-11

SECTORS PEERS

PEERPRICE
HBIO$7.96COMPARE
PASG$4.72COMPARE
COSM$0.28COMPARE
FEMY$3.00COMPARE
NCNA$1.41COMPARE
SNYR$0.10COMPARE